跳至主要内容
临床试验/NCT00256399
NCT00256399已完成不适用

A Prospective, Open Label, Study to Assess the Efficacy of Alfuzosin 10 mg Tablet Once a Day in Male Subjects Suffering From Benign Prostate Hypertrophy Associated Lower Urinary Tract Symptoms and Erectile Dysfunction

University Hospitals Cleveland Medical Center2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2005年11月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
6
试验地点
2
主要终点
Evaluate the medication on erection maintenance

研究概览

简要总结

Uroxatral (alfuzosin) may not only help BPH symptoms but may also improve sexual function in males with BPH and ED.

详细描述

The study will consist of a 30 day screening/washout phase at the end of which qualified subjects will be assigned to alfuzosin 10 mg tablets once a day. Subjects will be treated for 90 days. The total duration of the study will be 120 days.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
45 Years 至 75 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Males 45-75 years of age
  • Confirmed diagnosis of BPH/lower urinary tract symptoms (LUTS) and ED
  • Men with steady partner and who agree to attempt sex once a week.

排除标准

  • Prostate cancer
  • Prostatitis
  • Penile disease
  • Cardiac co-morbidity
  • Pre-existing co-morbid conditions
  • History of sensitivity to the drug or similar drugs
  • Enrollment in another clinical trial
  • Impaired hepatic function
  • Impaired renal function
  • Mental conditions rendering subject unable to understand the study
  • Subjects not likely to comply with protocol

结局指标

主要结局

Evaluate the medication on erection maintenance

次要结局

  • Assess effect of Uroxatral on BPH and sexual function using questionnaires

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Uroxatral in Men With Benign Prostate Hypertrophy... | 临床试验